Vimarsana
Biggest News Aggregation in the World

Page 5 - Van Rompay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Van Rompay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Van Rompay Today - Breaking & Trending Today

Hyloris Announces Commercial Partnership for Maxigesic® IV in 9 European Countries - Vimarsana News

Hyloris Announces Commercial Partnership for Maxigesic® IV in 9 European Countries

Hyloris Announces Commercial Partnership for Maxigesic® IV in 9 European Countries - read this article along with other careers information, tips and advice on BioSpace

Hyloris Pharmaceuticals Reports 2022 Half-Year Results and Provides Corporate Update - Vimarsana News

Hyloris Pharmaceuticals Reports 2022 Half-Year Results and Provides Corporate Update

01.09.2022 - - On track to broaden product pipeline to meet a target portfolio of 30 programs by 2024- Continued commercial rollout of Sotalol IV in US and Maxigesic IV - Focused entry into US market with Maxigesic IV for non-opioid pain treatment; continuing ...

Hyloris Successfully Raises EUR 15.0 Million in an Equity Offering by Means of A Private Placement Via an Accelerated Bookbuild Offering - Vimarsana News

Hyloris Successfully Raises EUR 15.0 Million in an Equity Offering by Means of A Private Placement Via an Accelerated Bookbuild Offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN VIOLATION OF THE RELEVANT LAWS... | April 1, 2022

Hyloris Pharmaceuticals SA: Hyloris Successfully Raises EUR 15.0 Million in an Equity Offering by Means of A Private Placement Via an Accelerated Bookbuild Offering - Vimarsana News

Hyloris Pharmaceuticals SA: Hyloris Successfully Raises EUR 15.0 Million in an Equity Offering by Means of A Private Placement Via an Accelerated Bookbuild Offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN VIOLATION OF THE RELEVANT LAWS OF

Hyloris Announces Start of Phase 2 Study of Miconazole-Domiphen Bromide Vaginal Cream in ... - Vimarsana News

Hyloris Announces Start of Phase 2 Study of Miconazole-Domiphen Bromide Vaginal Cream in ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com